glp-1 obesity drug news today september 29 2025 Could Weight Loss Drugs Also Treat or Prevent Chronic Diseases? GLP-1 Agonists Weight Loss Drugs

Over the past several years, the company repositioned entirely around pemvidutide, its balanced dual GLP-1/glucagon receptor agonist for obesity and liver disease

Maughan SC, Pasternak M, Cairns N, Kiddle G, Brach T, Jarvis R, Haas F, Nieuwland J, Lim B, Mller C, Salcedo-Sora E, Kruse C, Orsel M, Hell R, Miller AJ, Bray P, Foyer CH, Murray JAH, Meyer AJ, Cobbett CS (2010) Plant homologs of the Plasmodium falciparum chloroquine-resistance transporter, PfCRT, are required for glutathione homeostasis and stress responses

In animal models, topical GHK-Cu application significantly improved wound healing rates, increased collagen deposition, and enhanced the tensile strength of healed tissue

IN0031 Rev